project id: TCGA-ACC; case submitter id: TCGA-OR-A5LB; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.86; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.75; rna integrity number: 8.9; age at index: 59; days to birth: -21565; days to death: 1204; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1947; year of death: 2009; age at diagnosis: 21565; ajcc clinical m: M1; ajcc pathologic n: N0; ajcc pathologic stage: Stage IV; ajcc pathologic t: T4; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C74.0; last known disease status: not reported; morphology: 8370/3; primary diagnosis: Adrenal cortical carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cortex of adrenal gland; synchronous malignancy: Not Reported; tissue or organ of origin: Cortex of adrenal gland; tumor grade: Not Reported; year of diagnosis: 2006; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 2386; initial weight: 40.0; sample id: ed5579d8-352e-4586-ac94-5320e357e9fc; sample submitter id: TCGA-OR-A5LB-01A; portion id: 59560c70-0e85-4a83-9066-262d3c61b287; portion submitter id: TCGA-OR-A5LB-01A-11; slide id: b32d5a9d-9448-4321-a499-2ec543fefd3d; slide submitter id: TCGA-OR-A5LB-01A-01-TS1; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 10.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 90.0; percent tumor nuclei: 90.0; section location: TOP;